- Home
- YRD vs LXRX Comparison
YRD vs LXRX Comparison
Compare YRD & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YRD
- LXRX
- Stock Information
- Founded
- YRD 2012
- LXRX 1995
- Country
- YRD China
- LXRX United States
- Employees
- YRD N/A
- LXRX N/A
- Industry
- YRD Finance: Consumer Services
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- YRD Finance
- LXRX Health Care
- Exchange
- YRD Nasdaq
- LXRX Nasdaq
- Market Cap
- YRD 532.3M
- LXRX 428.8M
- IPO Year
- YRD 2015
- LXRX 2000
- Fundamental
- Price
- YRD $5.73
- LXRX $1.09
- Analyst Decision
- YRD
- LXRX Buy
- Analyst Count
- YRD 0
- LXRX 5
- Target Price
- YRD N/A
- LXRX $3.23
- AVG Volume (30 Days)
- YRD 88.0K
- LXRX 1.9M
- Earning Date
- YRD 08-21-2025
- LXRX 08-06-2025
- Dividend Yield
- YRD 7.68%
- LXRX N/A
- EPS Growth
- YRD N/A
- LXRX N/A
- EPS
- YRD 2.07
- LXRX N/A
- Revenue
- YRD $856,794,857.00
- LXRX $58,432,000.00
- Revenue This Year
- YRD N/A
- LXRX N/A
- Revenue Next Year
- YRD N/A
- LXRX N/A
- P/E Ratio
- YRD $2.76
- LXRX N/A
- Revenue Growth
- YRD 12.42
- LXRX 1504.83
- 52 Week Low
- YRD $4.37
- LXRX $0.28
- 52 Week High
- YRD $9.20
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- YRD 41.97
- LXRX 47.86
- Support Level
- YRD $5.71
- LXRX $1.03
- Resistance Level
- YRD $6.35
- LXRX $1.20
- Average True Range (ATR)
- YRD 0.18
- LXRX 0.06
- MACD
- YRD -0.02
- LXRX -0.01
- Stochastic Oscillator
- YRD 4.38
- LXRX 28.57
About YRD Yiren Digital Ltd.
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.